FR2525592A1 - - Google Patents

Download PDF

Info

Publication number
FR2525592A1
FR2525592A1 FR8207179A FR8207179A FR2525592A1 FR 2525592 A1 FR2525592 A1 FR 2525592A1 FR 8207179 A FR8207179 A FR 8207179A FR 8207179 A FR8207179 A FR 8207179A FR 2525592 A1 FR2525592 A1 FR 2525592A1
Authority
FR
France
Prior art keywords
cys
tyr
asn
ala
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8207179A
Other languages
English (en)
French (fr)
Other versions
FR2525592B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR8207179A priority Critical patent/FR2525592B1/fr
Priority to CA000426666A priority patent/CA1246054A/en
Priority to JP58072336A priority patent/JPS58201754A/ja
Priority to US06/488,712 priority patent/US4499080A/en
Priority to DE8383400827T priority patent/DE3368387D1/de
Priority to EP83400827A priority patent/EP0093652B1/fr
Publication of FR2525592A1 publication Critical patent/FR2525592A1/fr
Application granted granted Critical
Publication of FR2525592B1 publication Critical patent/FR2525592B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8207179A 1982-04-26 1982-04-26 Expired FR2525592B1 (enExample)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR8207179A FR2525592B1 (enExample) 1982-04-26 1982-04-26
CA000426666A CA1246054A (en) 1982-04-26 1983-04-25 Synthetic st toxin, process for its preparation and its use as a vaccinating agent
JP58072336A JPS58201754A (ja) 1982-04-26 1983-04-26 合成ｓｔ毒素、その製造方法およびそのワクチン接種剤としての用途
US06/488,712 US4499080A (en) 1982-04-26 1983-04-26 Synthetic ST toxin, process for its preparation and its use as a vaccinating agent
DE8383400827T DE3368387D1 (en) 1982-04-26 1983-04-26 Synthetic toxin st, process for its preparation and its use as a vaccination agent
EP83400827A EP0093652B1 (fr) 1982-04-26 1983-04-26 Toxine synthétique ST, son procédé de préparation et son application comme agent vaccinant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207179A FR2525592B1 (enExample) 1982-04-26 1982-04-26

Publications (2)

Publication Number Publication Date
FR2525592A1 true FR2525592A1 (enExample) 1983-10-28
FR2525592B1 FR2525592B1 (enExample) 1984-09-14

Family

ID=9273400

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8207179A Expired FR2525592B1 (enExample) 1982-04-26 1982-04-26

Country Status (6)

Country Link
US (1) US4499080A (enExample)
EP (1) EP0093652B1 (enExample)
JP (1) JPS58201754A (enExample)
CA (1) CA1246054A (enExample)
DE (1) DE3368387D1 (enExample)
FR (1) FR2525592B1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096318A (en) * 1973-05-07 2000-08-01 The Ohio State University Antigenically modified HCG polypeptides
US4767842A (en) * 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US5698201A (en) * 1973-05-07 1997-12-16 The Ohio State University Method for treatment of antigenically modified polypeptides
US5006334A (en) * 1973-05-07 1991-04-09 The Ohio State University Antigenic modification of polypeptides
US6039948A (en) * 1973-05-07 2000-03-21 The Ohio State University Method for treatment of antigenically modified polypeptides
US4762913A (en) * 1973-05-07 1988-08-09 The Ohio State University Antigenic modification of polypeptides
US6143305A (en) * 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US4886663A (en) * 1983-01-03 1989-12-12 Scripps Clinic And Research Foundation Synthetic heat-stable enterotoxin polypeptide of Escherichia coli and multimers thereof
US4578217A (en) * 1983-05-12 1986-03-25 New York Blood Center, Inc. Synthetic antigenic peptide derived from hepatitis B surface antigen
US4575495A (en) * 1983-05-12 1986-03-11 New York Blood Center, Inc. Synthetic antigenic peptide derived from Hepatitis B surface antigen
IL69558A (en) * 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
FR2551088B1 (enExample) * 1983-08-29 1985-12-06 Pasteur Institut
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US4855285A (en) * 1985-12-04 1989-08-08 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5817753A (en) * 1985-12-04 1998-10-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
US4929718A (en) * 1987-12-14 1990-05-29 Universidad Nacional Autonoma De Mexico Synthetic noxiustoxin related peptides
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
KR960013600B1 (ko) * 1989-06-02 1996-10-09 제네틱 시스팀스 코포레이션 면역분석법에 이용되는 시스테인 티올-보호 펩티드
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
TW227004B (enExample) * 1990-12-19 1994-07-21 Hoechst Ag
JP2955082B2 (ja) * 1991-10-11 1999-10-04 大阪瓦斯株式会社 ヒトカルシトニンのｎ末端部分を特異的に認識するモノクローナル抗体
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
JP4037933B2 (ja) * 1996-12-24 2008-01-23 大阪瓦斯株式会社 抗ヒトカルシトニンモノクローナル抗体
US6008378A (en) * 1997-10-21 1999-12-28 The Regents Of The University Of California Synthetic molecules that specifically react with target sequences
WO1999042098A1 (en) 1998-02-24 1999-08-26 Dovetail Technologies Inc. Small molecules that increase the conversion of food to body weight gain
EP2355846A4 (en) * 2008-09-03 2013-06-19 Univ Michigan State IMMUNOGENIC HEAT STABILIZER ESCHERICHIA COLI-ENTEROTOXIN

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2380296A1 (fr) * 1977-02-10 1978-09-08 Otsuka Pharma Co Ltd Procede pour preparer un antigene et un anticorps
EP0018189A2 (en) * 1979-04-18 1980-10-29 Connaught Laboratories Limited Synthetic adjuvants for stimulating antigenic responses
US4290944A (en) * 1980-07-31 1981-09-22 Northwestern University Antigenic peptide compound
EP0037522A2 (fr) * 1980-04-04 1981-10-14 Smith Kline - RIT Société anonyme dite: Dérivés de l'entérotoxine thermostable de Escherichia Coli et leur préparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2380296A1 (fr) * 1977-02-10 1978-09-08 Otsuka Pharma Co Ltd Procede pour preparer un antigene et un anticorps
EP0018189A2 (en) * 1979-04-18 1980-10-29 Connaught Laboratories Limited Synthetic adjuvants for stimulating antigenic responses
EP0037522A2 (fr) * 1980-04-04 1981-10-14 Smith Kline - RIT Société anonyme dite: Dérivés de l'entérotoxine thermostable de Escherichia Coli et leur préparation
US4290944A (en) * 1980-07-31 1981-09-22 Northwestern University Antigenic peptide compound

Also Published As

Publication number Publication date
EP0093652A1 (fr) 1983-11-09
FR2525592B1 (enExample) 1984-09-14
JPS58201754A (ja) 1983-11-24
DE3368387D1 (en) 1987-01-29
US4499080A (en) 1985-02-12
EP0093652B1 (fr) 1986-12-17
CA1246054A (en) 1988-12-06

Similar Documents

Publication Publication Date Title
EP0093652B1 (fr) Toxine synthétique ST, son procédé de préparation et son application comme agent vaccinant
US5589459A (en) Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
JP2573815B2 (ja) マイコバクテリウム感染検出合成ポリペプチド
JPH06501938A (ja) ペプチドよりなるｈｉｖ複製阻害剤
FR2617170A1 (fr) Nouveaux derives peptidiques et leur application notamment en therapeutique
US5223604A (en) Pseudomonas exoenzyme s peptide composition and method
FR2672290A1 (fr) Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
EP0750508B1 (fr) RETROPEPTIDES, ANTICORPS DIRIGES CONTRE CES DERNIERS, ET LEURS UTILISATIONS POUR LA VACCINATION ET LE DIAGNOSTIC $i(IN VITRO)
EP0538352B1 (fr) SEQUENCE PEPTIDIQUE IMMUNOGENE D'$i(ECHINOCOCCUS GRANULOSUS), SEQUENCE D'ADN CODANT POUR CETTE SEQUENCE PEPTIDIQUE ET APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
FR2482861A1 (fr) Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal
HUT52787A (en) Process for production of biologically active peptides
EP0569309B1 (fr) Polypeptides de synthèse appartenant au virus de l'hépatite C (VHC) et utilisables notamment pour détecter ce dernier
FR2550943A1 (fr) Vaccin synthetique contre le cholera
EP0323769B1 (fr) Structures peptidiques, immunogènes les contenant et leurs applications au contrôle de la fertilité
FR2608160A1 (fr) Nouveaux derives peptidiques et leur application notamment en therapeutique
AU652611B2 (en) Analogs of piscine LHRH
FR2729960A1 (fr) Polypeptides mimotopes de toxoplasma gondii et applications
WO1989000166A2 (en) Growth hormone related peptide
FR2532850A1 (fr) Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention
EP0284492A1 (fr) Nouvelles fractions peptidiques inductrices d'anticorps protecteurs contre le virus de la leucémie bovine, procédé pour l'obtention de telles fractions, leurs séquences codantes et vaccins réalisés à partir de ces fractions
JPH02504632A (ja) 生物学的活性分子
EP0139555B1 (fr) Nouveau peptide de synthèse, son procédé de préparation et médicaments le contenant
FR2558165A1 (fr) Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages
EP0348399B1 (fr) Sorbine et peptides derives, elevant l'absorption par les muqueuses
FR2669339A1 (fr) Nouveaux derives peptidiques, procede de preparation et application a titre de medicaments de ces nouveaux derives.

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 43/83

ST Notification of lapse